BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32864840)

  • 1. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study.
    Zhong Q; Chen QY; Parisi A; Ma YB; Lin GT; Desiderio J; Yan S; Xie JW; Wang JB; Hou JF; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Liu ZY; Que SJ; Li P; Zheng CH; Huang CM
    Oncologist; 2021 Jan; 26(1):e99-e110. PubMed ID: 32864840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification.
    Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Kakeji Y
    Eur J Surg Oncol; 2022 Aug; 48(8):1760-1767. PubMed ID: 35094909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
    Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
    Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of ypTNM Stage Grouping in the 8th Edition of the American Joint Committee on Cancer TNM Staging System for Esophageal Squamous Cell Carcinoma.
    Sudo N; Ichikawa H; Muneoka Y; Hanyu T; Kano Y; Ishikawa T; Hirose Y; Miura K; Shimada Y; Nagahashi M; Sakata J; Kobayashi T; Bamba T; Nakagawa S; Kosugi SI; Wakai T
    Ann Surg Oncol; 2021 Feb; 28(2):650-660. PubMed ID: 33025354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
    Lin JX; Yoon C; Desiderio J; Yi BC; Li P; Zheng CH; Parisi A; Huang CM; Strong VE; Yoon SS
    Br J Surg; 2019 Aug; 106(9):1187-1196. PubMed ID: 31197829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel ypTLM Staging System Based on LODDS for Gastric Cancer After Neoadjuvant Therapy: Multicenter and Large-Sample Retrospective Study.
    Que SJ; Zhong Q; Chen QY; Truty MJ; Yan S; Ma YB; Ding FH; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Lin JL; Zheng HL; Huang CM
    World J Surg; 2023 Jul; 47(7):1762-1771. PubMed ID: 37069317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma.
    Kang J; Lee HP; Kim HR; Kim JH; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Ahn JY; Ryu JS; Cho KJ; Lee MY; Kim SB; Kim YH; Park SR
    Surg Oncol; 2020 Dec; 35():491-497. PubMed ID: 33130441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ypTNM staging after neoadjuvant chemotherapy in the Chinese gastric cancer population: an evaluation on the prognostic value of the AJCC eighth edition cancer staging system.
    Li Z; Wang Y; Shan F; Ying X; Wu Z; Xue K; Miao R; Zhang Y; Ji J
    Gastric Cancer; 2018 Nov; 21(6):977-987. PubMed ID: 29748876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A better prognostic stratification for the 8th edition of the AJCC staging system of gastric cancer by incorporating pT4aN0M0 into stage IIIA.
    Chen Y; Zhang G; Zhao B; Huang C; Ling Y; Li Y; Zhou Z
    Surg Oncol; 2019 Jun; 29():90-96. PubMed ID: 31196500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
    Kantor O; Bao J; Jaskowiak N; Yao K; Tseng J
    Ann Surg Oncol; 2020 Feb; 27(2):352-358. PubMed ID: 31376037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis.
    Yuan SQ; Chen YT; Huang ZP
    J Gastrointest Surg; 2017 Oct; 21(10):1591-1598. PubMed ID: 28752402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China.
    Ye J; Ren Y; Wei Z; Hou X; Dai W; Cai S; Tan M; He Y; Yuan Y
    Surg Oncol; 2018 Jun; 27(2):146-153. PubMed ID: 29937164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
    Wong IYH; Chung JCY; Zhang RQ; Gao X; Lam KO; Kwong DLW; Chao YK; Law SYK
    Ann Surg; 2022 Nov; 276(5):784-791. PubMed ID: 35876374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.
    Sisic L; Blank S; Nienhüser H; Dorr S; Haag GM; Jäger D; Bruckner T; Müller-Stich BP; Ott K; Büchler MW; Ulrich A; Schmidt T
    Eur J Surg Oncol; 2018 Oct; 44(10):1646-1656. PubMed ID: 30082176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development trend of assessment system in gastric cancer based on evolution of staging criteria].
    Sun L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1113-1120. PubMed ID: 30370509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio-based the ypTNrM staging system for gastric cancer after neoadjuvant therapy: a large population-based study.
    Chen JX; Sun JW; Wang Y; Pan T; Zhuang LP; Lin LZ; Lv BC
    Surg Today; 2022 May; 52(5):783-794. PubMed ID: 34724107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a staging system and survival prediction model for advanced gastric cancer patients without adjuvant treatment after curative gastrectomy: A retrospective multicenter cohort study.
    Park KB; Jun KH; Song KY; Chin H; Lee HH
    Int J Surg; 2022 May; 101():106629. PubMed ID: 35460886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the 8th Edition of the AJCC TNM Staging System Sufficiently Reasonable for All Patients with Noncardia Gastric Cancer? A 12,549-Patient International Database Study.
    Lu J; Zheng ZF; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Zheng CH; Li P
    Ann Surg Oncol; 2018 Jul; 25(7):2002-2011. PubMed ID: 29725896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed Modification of the 8th Edition of the AJCC Staging System for Gastric Cancer.
    Jiang Y; Tu R; Lu J; Zhang Y; Zhu J; Tang W; Gu M; Huang C; Gu X
    J Invest Surg; 2020 Dec; 33(10):932-938. PubMed ID: 30885025
    [No Abstract]   [Full Text] [Related]  

  • 20. Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database.
    Lin JX; Lin JP; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM
    Eur J Surg Oncol; 2018 Aug; 44(8):1205-1211. PubMed ID: 29804693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.